CRISPR Therapeutics among healthcare gainers; Plus Therapeutics leads the losers
### Instruction: What is the sentiment of this news? Please choose an answer from {negative/neutral/positive}
### Input: CRISPR Therapeutics among healthcare gainers; Plus Therapeutics leads the losers
### Response: neutral